Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


14.05.2018

1 Br J Psychiatry
1 Can J Psychiatry
1 J Abnorm Psychol
2 Mol Psychiatry
3 Neuropsychopharmacology
3 PLoS One
1 Psychiatry Res
4 Psychol Med
5 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Br J Psychiatry

  1. MARWICK KFM, Stevenson AJ, Davies C, Lawrie SM, et al
    Application of n-of-1 treatment trials in schizophrenia: systematic review.
    Br J Psychiatry. 2018 May 10:1-6. doi: 10.1192/bjp.2018.
    PubMed     Text format     Abstract available


    Can J Psychiatry

  2. WINSHIP IR, Dursun SM, Baker GB, Balista PA, et al
    An Overview of Animal Models Related to Schizophrenia.
    Can J Psychiatry. 2018 Jan 1:706743718773728. doi: 10.1177/0706743718773728.
    PubMed     Text format     Abstract available


    J Abnorm Psychol

  3. DEMMIN DL, Davis Q, Roche M, Silverstein SM, et al
    Electroretinographic anomalies in schizophrenia.
    J Abnorm Psychol. 2018;127:417-428.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  4. PILLINGER T, D'Ambrosio E, McCutcheon R, D Howes O, et al
    Is psychosis a multisystem disorder? A meta-review of central nervous system, immune, cardiometabolic, and endocrine alterations in first-episode psychosis and perspective on potential models.
    Mol Psychiatry. 2018 May 9. pii: 10.1038/s41380-018-0058.
    PubMed     Text format     Abstract available

  5. HAUBERG ME, Fullard JF, Zhu L, Cohain AT, et al
    Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls.
    Mol Psychiatry. 2018 May 8. pii: 10.1038/s41380-018-0059.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  6. CHIAPPELLI J, Rowland LM, Notarangelo FM, Wijtenburg SA, et al
    Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia.
    Neuropsychopharmacology. 2018 Apr 18. pii: 10.1038/s41386-018-0072.
    PubMed     Text format     Abstract available

  7. ERMAKOVA AO, Knolle F, Justicia A, Bullmore ET, et al
    Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis.
    Neuropsychopharmacology. 2018 Apr 5. pii: 10.1038/s41386-018-0056.
    PubMed     Text format     Abstract available

  8. HAFIZI S, Da Silva T, Meyer JH, Kiang M, et al
    Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study.
    Neuropsychopharmacology. 2018 Apr 13. pii: 10.1038/s41386-018-0061.
    PubMed     Text format     Abstract available


    PLoS One

  9. GISSELGARD J, Lebedev AV, Daehli Kurz K, Joa I, et al
    Structural and functional alterations in the brain during working memory in medication-naive patients at clinical high-risk for psychosis.
    PLoS One. 2018;13:e0196289.
    PubMed     Text format     Abstract available

  10. EGLOFF L, Studerus E, Zimmermann R, Heitz U, et al
    Evaluating verbal learning and memory in patients with an at-risk mental state or first episode psychosis using structural equation modelling.
    PLoS One. 2018;13:e0196936.
    PubMed     Text format     Abstract available

  11. RASSOVSKY Y, Dunn W, Wynn JK, Wu AD, et al
    Single transcranial direct current stimulation in schizophrenia: Randomized, cross-over study of neurocognition, social cognition, ERPs, and side effects.
    PLoS One. 2018;13:e0197023.
    PubMed     Text format     Abstract available


    Psychiatry Res

  12. ZHOU W, Shi Y, Li F, Wu X, et al
    Study of the association between Schizophrenia and microduplication at the 16p11.2 locus in the Han Chinese population.
    Psychiatry Res. 2018;265:198-199.
    PubMed     Text format     Abstract available


    Psychol Med

  13. HALLGREN M, Skott M, Ekblom O, Firth J, et al
    Exercise effects on cognitive functioning in young adults with first-episode psychosis: FitForLife.
    Psychol Med. 2018 May 6:1-9. doi: 10.1017/S0033291718001022.
    PubMed     Text format     Abstract available

  14. TAKAYANAGI Y, Sasabayashi D, Takahashi T, Komori Y, et al
    Altered brain gyrification in deficit and non-deficit schizophrenia.
    Psychol Med. 2018 May 9:1-8. doi: 10.1017/S0033291718001228.
    PubMed     Text format     Abstract available

  15. JESSEN K, Rostrup E, Mandl RCW, Nielsen MO, et al
    Cortical structures and their clinical correlates in antipsychotic-naive schizophrenia patients before and after 6 weeks of dopamine D2/3 receptor antagonist treatment.
    Psychol Med. 2018 May 8:1-10. doi: 10.1017/S0033291718001198.
    PubMed     Text format     Abstract available

  16. PALANIYAPPAN L, Hodgson O, Balain V, Iwabuchi S, et al
    Structural covariance and cortical reorganisation in schizophrenia: a MRI-based morphometric study.
    Psychol Med. 2018 May 6:1-9. doi: 10.1017/S0033291718001010.
    PubMed     Text format     Abstract available


    Schizophr Res

  17. POLETTI M, Raballo A
    Polygenic Risk Score and the (neuro)developmental ontogenesis of the schizophrenia spectrum vulnerability phenotypes.
    Schizophr Res. 2018 May 4. pii: S0920-9964(18)30249.
    PubMed     Text format    

  18. MEYER-KALOS PS, Ludwig KA, Gaylord S, Perkins DO, et al
    Enhancing stress reactivity and wellbeing in early schizophrenia: A pilot study of individual coping awareness therapy (I-CAT).
    Schizophr Res. 2018 May 4. pii: S0920-9964(18)30253.
    PubMed     Text format    

  19. WANG H, Zhang B, Zeng B, Tang Y, et al
    Association between catechol-O-methyltransferase genetic variation and functional connectivity in patients with first-episode schizophrenia.
    Schizophr Res. 2018 May 3. pii: S0920-9964(18)30236.
    PubMed     Text format     Abstract available

  20. ARRANZ S, Monferrer N, Jose Algora M, Cabezas A, et al
    The relationship between the level of exposure to stress factors and cannabis in recent onset psychosis.
    Schizophr Res. 2018 May 6. pii: S0920-9964(18)30255.
    PubMed     Text format     Abstract available

  21. GUERCIO GD, Thomas ME, Cisneros-Franco JM, Voss P, et al
    Improving cognitive training for schizophrenia using neuroplasticity enhancers: Lessons from decades of basic and clinical research.
    Schizophr Res. 2018 May 2. pii: S0920-9964(18)30241.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: